Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Karol Perlejewski

Biographic Data

ID8871092
NAMEKarol Perlejewski
GIVEN NAMESKarol
FAMILY NAMEPerlejewski
SIGNATUREPERLEJEWSKI K
AFFILIATIONSMedical University of Warsaw
ORCID0000-0002-3782-6442
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2024
H-INDEX0
  • The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin

    Tomasz Pawłowski, Marek Radkowski et al.•ARTICLE•Psychosomatic Medicine•2024

    BACKGROUND: Sustained virological response (SVR) is the best indicator of successful therapy for hepatitis C virus (HCV) infection. Patients with chronic HCV infection treated with pegylated interferon-α and ribavirin (PEG-IFN-α/RBV) can achieve SVR 56% of the time. OBJECTIVES: This study aimed to evaluate baseline predictors of SVR in patients treated with PEG-IFN-α/RBV for HCV chronic infection. METHODS: A total of 101 patients receiving PEG-IF…

  • Next-Generation Sequencing of Hepatitis C Virus (HCV) Mixed-Genotype Infections in Anti-HCV-Negative Blood Donors

    Open Access•Maciej Janiak, Kamila Caraballo Cortés et al.•CHAPTER•Rehabilitation Science in Context•2018

No prominent works on this page.

  • Next-Generation Sequencing of Hepatitis C Virus (HCV) Mixed-Genotype Infections in Anti-HCV-Negative Blood Donors

    Open Access•Maciej Janiak, Kamila Caraballo Cortés et al.•CHAPTER•Rehabilitation Science in Context•2018

  • The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin

    Tomasz Pawłowski, Marek Radkowski et al.•ARTICLE•Psychosomatic Medicine•2024

    BACKGROUND: Sustained virological response (SVR) is the best indicator of successful therapy for hepatitis C virus (HCV) infection. Patients with chronic HCV infection treated with pegylated interferon-α and ribavirin (PEG-IFN-α/RBV) can achieve SVR 56% of the time. OBJECTIVES: This study aimed to evaluate baseline predictors of SVR in patients treated with PEG-IFN-α/RBV for HCV chronic infection. METHODS: A total of 101 patients receiving PEG-IF…

Hepatitis C (2 works) · Hepatitis C virus (2 works) · Hepatitis C virus research (2 works) · Medicine (2 works) · Virus (2 works) · Biology (1 works) · Cardiac Health and Mental Health (1 works) · Cohort (1 works) · Confidence interval (1 works) · Depression (economics) (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae